Logo image of BZUN

BAOZUN INC-SPN ADR (BZUN) Stock Fundamental Analysis

NASDAQ:BZUN - Nasdaq - US06684L1035 - ADR - Currency: USD

3.23  -0.12 (-3.58%)

After market: 3.2 -0.03 (-0.93%)

Fundamental Rating

3

BZUN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 32 industry peers in the Broadline Retail industry. BZUN has a bad profitability rating. Also its financial health evaluation is rather negative. BZUN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BZUN has reported negative net income.
The reported net income has been mixed in the past 5 years: BZUN reported negative net income in multiple years.
In multiple years BZUN reported negative operating cash flow during the last 5 years.
BZUN Yearly Net Income VS EBIT VS OCF VS FCFBZUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

BZUN's Return On Assets of -2.66% is on the low side compared to the rest of the industry. BZUN is outperformed by 67.74% of its industry peers.
BZUN's Return On Equity of -6.79% is in line compared to the rest of the industry. BZUN outperforms 45.16% of its industry peers.
Industry RankSector Rank
ROA -2.66%
ROE -6.79%
ROIC N/A
ROA(3y)-3.63%
ROA(5y)-0.57%
ROE(3y)-9.09%
ROE(5y)-1.87%
ROIC(3y)N/A
ROIC(5y)N/A
BZUN Yearly ROA, ROE, ROICBZUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 -15

1.3 Margins

With an excellent Gross Margin value of 72.66%, BZUN belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
BZUN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BZUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.19%
GM growth 5Y3.13%
BZUN Yearly Profit, Operating, Gross MarginsBZUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

BZUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BZUN has more shares outstanding
Compared to 5 years ago, BZUN has more shares outstanding
Compared to 1 year ago, BZUN has a worse debt to assets ratio.
BZUN Yearly Shares OutstandingBZUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
BZUN Yearly Total Debt VS Total AssetsBZUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.25, we must say that BZUN is in the distress zone and has some risk of bankruptcy.
BZUN has a worse Altman-Z score (1.25) than 70.97% of its industry peers.
BZUN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.40, BZUN is in line with its industry, outperforming 45.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 1.25
ROIC/WACCN/A
WACC6.13%
BZUN Yearly LT Debt VS Equity VS FCFBZUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

BZUN has a Current Ratio of 1.94. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BZUN (1.94) is better than 64.52% of its industry peers.
A Quick Ratio of 1.66 indicates that BZUN should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.66, BZUN is doing good in the industry, outperforming 70.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.66
BZUN Yearly Current Assets VS Current LiabilitesBZUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

4

3. Growth

3.1 Past

BZUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -232.62%.
BZUN shows a small growth in Revenue. In the last year, the Revenue has grown by 4.90%.
Measured over the past years, BZUN shows a quite strong growth in Revenue. The Revenue has been growing by 10.32% on average per year.
EPS 1Y (TTM)-232.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.48%
Revenue 1Y (TTM)4.9%
Revenue growth 3Y-0.15%
Revenue growth 5Y10.32%
Sales Q2Q%16.4%

3.2 Future

Based on estimates for the next years, BZUN will show a very strong growth in Earnings Per Share. The EPS will grow by 76.92% on average per year.
Based on estimates for the next years, BZUN will show a small growth in Revenue. The Revenue will grow by 5.37% on average per year.
EPS Next Y126.22%
EPS Next 2Y99.97%
EPS Next 3Y73.09%
EPS Next 5Y76.92%
Revenue Next Year5.4%
Revenue Next 2Y5.05%
Revenue Next 3Y5.06%
Revenue Next 5Y5.37%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BZUN Yearly Revenue VS EstimatesBZUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
BZUN Yearly EPS VS EstimatesBZUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

BZUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
BZUN is valuated reasonably with a Price/Forward Earnings ratio of 10.72.
Based on the Price/Forward Earnings ratio, BZUN is valued a bit cheaper than 74.19% of the companies in the same industry.
BZUN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.56.
Industry RankSector Rank
PE N/A
Fwd PE 10.72
BZUN Price Earnings VS Forward Price EarningsBZUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BZUN Per share dataBZUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BZUN's earnings are expected to grow with 73.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y99.97%
EPS Next 3Y73.09%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BZUN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAOZUN INC-SPN ADR

NASDAQ:BZUN (1/31/2025, 8:15:19 PM)

After market: 3.2 -0.03 (-0.93%)

3.23

-0.12 (-3.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-21 2024-11-21/bmo
Earnings (Next)N/A N/A
Inst Owners22.13%
Inst Owner Change-0.16%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap186.44M
Analysts82.22
Price Target3.48 (7.74%)
Short Float %4.89%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.1%
Min EPS beat(2)-58.25%
Max EPS beat(2)14.05%
EPS beat(4)2
Avg EPS beat(4)-288.83%
Min EPS beat(4)-1178.43%
Max EPS beat(4)67.32%
EPS beat(8)2
Avg EPS beat(8)-181.89%
EPS beat(12)5
Avg EPS beat(12)-231.23%
EPS beat(16)8
Avg EPS beat(16)-159.64%
Revenue beat(2)0
Avg Revenue beat(2)-0.93%
Min Revenue beat(2)-0.94%
Max Revenue beat(2)-0.91%
Revenue beat(4)0
Avg Revenue beat(4)-3.67%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)-0.91%
Revenue beat(8)1
Avg Revenue beat(8)-2.67%
Revenue beat(12)1
Avg Revenue beat(12)-3.24%
Revenue beat(16)4
Avg Revenue beat(16)-2.28%
PT rev (1m)3.06%
PT rev (3m)3.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.72
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.39
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)0.3
Fwd EY9.33%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS21.05
BVpS9.79
TBVpS8.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.66%
ROE -6.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.66%
FCFM N/A
ROA(3y)-3.63%
ROA(5y)-0.57%
ROE(3y)-9.09%
ROE(5y)-1.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.19%
GM growth 5Y3.13%
F-ScoreN/A
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.66
Altman-Z 1.25
F-ScoreN/A
WACC6.13%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-232.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.48%
EPS Next Y126.22%
EPS Next 2Y99.97%
EPS Next 3Y73.09%
EPS Next 5Y76.92%
Revenue 1Y (TTM)4.9%
Revenue growth 3Y-0.15%
Revenue growth 5Y10.32%
Sales Q2Q%16.4%
Revenue Next Year5.4%
Revenue Next 2Y5.05%
Revenue Next 3Y5.06%
Revenue Next 5Y5.37%
EBIT growth 1Y-468.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year244.66%
EBIT Next 3Y81.81%
EBIT Next 5Y59.66%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A